Anthony H. Cincotta, PhD
“Our company is dedicated to understanding and applying nature’s genius to successfully treat human disease and thereby improve the human condition.”
Creators of Cycloset®*, the first and only FDA approved sympatholytic dopamine D2 receptor agonist for the treatment of type 2 diabetes.
*See full prescribing info
A post type for your testimonials
“Our company is dedicated to understanding and applying nature’s genius to successfully treat human disease and thereby improve the human condition.”